United States Anesthesia & Respiratory Devices Medical Equipment Industry Report

Published by: Global Markets Direct

Published: May. 2, 2008 - 366 Pages

Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

2.2 Definitions

2.2.1 Anesthesia and Respiratory Devices

3 Healthcare Sector Review

3.1 Healthcare Expenditure

3.2 Healthcare Infrastructure

3.2.1 Healthcare Personnel Data

3.2.2 Healthcare Facilities Data

4 Anesthesia and Respiratory Devices in United States

4.1 Anesthesia and Respiratory Devices Overall Revenues (2000-2012)

4.2 Anesthesia and Respiratory Devices Overall Volumes (2000-2012)

4.3 Anesthesia and Respiratory Devices Overall Company Share (2005-2006)

5 Respiratory Devices in United States

5.1 Respiratory Devices Overall Revenues (2000-2012)

5.1.1 Inhalers Overall Revenues (2000-2012)

5.1.2 Continuous Positive Airway Pressure (CPAP) Overall Revenues (2000-2012)

5.1.3 Nebulizers Overall Revenues (2000-2012)

5.1.4 Ventilators Overall Revenues (2000-2012)

5.1.5 Humidifiers Overall Revenues (2000-2012)

5.1.6 Oxygen Concentrators Overall Revenues (2000-2012)

5.1.7 Resuscitators Overall Revenues (2000-2012)

5.2 Respiratory Devices Overall Volumes (2000-2012)

5.2.1 Inhalers Overall Volumes (2000-2012)

5.2.2 Nebulizers Overall Volume (2000-2012)

5.2.3 Humidifiers Overall Volume (2000-2012)

5.2.4 Ventilators Overall Volume (2000-2012)

5.2.5 Resuscitators Overall Volume (2000-2012)

5.2.6 Continuous Positive Airway Pressure Devices Overall Volume (2000-2012)

5.2.7 Oxygen Concentrators Overall Volume (2000-2012)

5.3 Respiratory Devices Average Price (2000-2012)

5.3.1 Continuous Positive Airway Pressure (CPAP) Devices Average Price (2000-2012)

5.3.2 Inhalers Average Price (2000-2012)

5.3.3 Resuscitators Average Price (2000-2012)

5.3.4 Ventilators Average Price (2000-2012)

5.3.5 Humidifiers Average Price (2000-2012)

5.3.6 Nebulizers Average Price (2000-2012)

5.3.7 Oxygen Concentrator Average Price (2000-2012)

5.4 Respiratory Devices Distribution Share (2005-2006)

5.5 Respiratory Devices Company Share (2005-2006)

6 Respiratory Measurement Devices in United States

6.1 Respiratory Measurement Devices Overall Revenues (2000-2012)

6.1.1 Pulse Oximetry Sensors Overall Revenues (2000-2012)

6.1.2 Capnographs Overall Revenues (2000-2012)

6.1.3 Spirometers Overall Revenues (2000-2012)

6.2 Respiratory Measurement Devices Category Volume (2000-2012)

6.2.1 Pulse Oximetry Sensors Overall Volume (2000-2012)

6.2.2 Capnographs Overall Volume (2000-2012)

6.2.3 Spirometers Overall Volume (2000-2012)

6.3 Respiratory Measurement Devices Average Price (2000-2012)

6.3.1 Pulse Oximetry Sensors Average Price (2000-2012)

6.3.2 Capnographs Average Price (2000-2012)

6.3.3 Spirometers Average Price (2000-2012)

6.4 Respiratory Measurement Devices Distribution Share (2005-2006)

6.5 Respiratory Measurement Devices Company Share (2005-2006)

7 Respiratory Disposables in United States

7.1 Respiratory Disposables Overall Revenues (2000-2012)

7.1.1 Disposable Tracheostomy Tubes Overall Revenues (2000-2012)

7.1.2 Laryngeal Mask Airways (LMAs) Overall Revenues (2000-2012)

7.1.3 Disposable Endotracheal Tubes Overall Revenues (2000-2012)

7.1.4 Disposable Oxygen Masks Overall Revenues (2000-2012)

7.1.5 Oxygen Cannulae Overall Revenues (2000-2012)

7.2 Respiratory Disposables Overall Volume (2000-2012)

7.2.1 Oxygen Cannulae Overall Volume (2000-2012)

7.2.2 Disposable Oxygen Masks Overall Volume (2000-2012)

7.2.3 Disposable Endotracheal Tubes Overall Volume (2000-2012)

7.2.4 Laryngeal Mask Airways (LMAs) Overall Volume (2000-2012)

7.2.5 Disposable Tracheostomy Tubes Overall Volume (2000-2012)

7.3 Respiratory Disposables Average Price (2000-2012)

7.3.1 Disposable Oxygen Masks Average Price (2000-2012)

7.3.2 Oxygen Cannulae Average Price (2000-2012)

7.3.3 Disposable Tracheostomy Tubes Average Price (2000-2012)

7.3.4 Disposable Endotracheal Tubes Average Price (2000-2012)

7.3.5 Laryngeal Mask Airways (LMAs) Average Price (2000-2012)

7.4 Respiratory Disposables Distribution Share (2005-2006)

7.5 Respiratory Disposables Company Share (2005-2006)

8 Anesthesia Machines in United States

8.1 Anesthesia Machines Overall Revenues (2000-2012)

8.2 Anesthesia Machines Category Volume (2000-2012)

8.3 Anesthesia Machines Average Price (2000-2012)

8.4 Anesthesia Machines Distribution Share (2005-2006)

8.5 Anesthesia Machines Company Share (2005-2006)

9 Anesthesia Disposables in United States

9.1 Anesthesia Disposables Overall Revenues (2000-2012)

9.1.1 Anesthesia Circuits Overall Revenues (2000-2012)

9.1.2 Anesthesia Masks Overall Revenues (2000-2012)

9.2 Anesthesia Disposables Overall Volume (2000-2012)

9.2.1 Anesthesia Masks Overall Volume (2000-2012)

9.2.2 Anesthesia Circuits Overall Volume (2000-2012)

9.3 Anesthesia Disposables Average Price (2000-2012)

9.3.1 Anesthesia Circuits Average Price (2000-2012)

9.3.2 Anesthesia Masks Average Price (2000-2012)

9.4 Anesthesia Disposables Distribution Share (2005-2006)

9.5 Anesthesia Disposables Company Share (2005-2006)

10 GE Healthcare Company Profile

10.1 Company Overview

10.2 Business Overview

10.2.1 Products

10.3 Locations And Subsidiaries

10.4 Financial Deals Landscape

10.4.1 GE Healthcare Acquires Image Diagnost International

10.4.2 GE Healthcare Acquires Dynamic Imaging

10.4.3 GE Healthcare And The Medipattern Enter Into An Agreement

10.4.4 Ge Healthcare Signs An Agreement With Nordiag

10.4.5 GE Healthcare And Omron Healthcare Enter Into Distribution Agreement

10.4.6 GE Healthcare Acquires Wave Biotech

10.4.7 PhotoCure enters into licensing agreement with GE Healthcare

10.4.8 GE Healthcare And Awarix Enter Into A Partnership Agreement

10.4.9 Ge Healthcare Signs An Agreement With Applied Biosystems

10.4.10 Ge Healthcare Signs An Agreement With Parker Domnick Hunter

10.4.11 BIOTRONIK Signs An Agreement With GE Healthcare

10.4.12 GE Healthcare To Acquire Whatman

10.4.13 GE Healthcare terminates the acquisition of In vitro diagnostics and Point-of-Care diagnostics businesses of Abbott

10.4.14 Abbott Terminates The Deal To Divest Its Divisions To GE Healthcare

10.5 Recent Developments

10.5.1 Dec 20, 2007: DRAXIMAGE Appoints GE Healthcare As Distributor Of DRAXIMAGE(R) Sestamibi In US

10.5.2 Dec 18, 2007: Confirma Expands Strategic Partnership With GE Healthcare

10.5.3 Oct 10, 2007: GE Healthcare Appoints CTO

10.5.4 Jun 26, 2007: Medipattern Signs Sales And Development Agreement With GE

10.5.5 Jun 01, 2007: I-Flow Forms Strategic Alliance With GE Healthcare

10.5.6 Apr 19, 2007: OMRON, GE Enter Distribution Agreement

10.6 GE Healthcare Pipeline Products

10.6.1 Gemstone CT detector

10.6.2 Vivid e 08

10.6.3 LOGIQ e

10.6.4 Logiq Book XP (Upgradation)

10.6.5 Modified lightSpeed VCT scanner

10.6.6 Responder

11 Cardinal Health, Inc. Company Profile

11.1 Company Overview

11.2 Business Overview

11.2.1 Clinical Technologies and Services

11.2.2 Medical Products and Services

11.2.3 Pharmaceutical Distribution and Provider Services

11.2.4 Pharmaceutical Technologies and Services

11.2.5 Products

11.2.6 History

11.3 Value Chain Analysis

11.3.1 Manufacturing

11.3.2 Product Development

11.3.3 Sales and Marketing

11.4 SWOT Analysis

11.4.1 Cardinal Health, Inc. Strengths

11.4.2 Cardinal Health, Inc. Weaknesses

11.4.3 Cardinal Health, Inc. Opportunities

11.4.4 Cardinal Health, Inc. Threats

11.5 Financial and Operational Review

11.6 Locations And Subsidiaries

11.7 Financial Deals Landscape

11.7.1 Cardinal Health Signs An Agreement With ClearCount Medical Solutions

11.7.2 Cardinal Health And Alliance Boots Forms A Joint Venture

11.7.3 Cardinal Health Signs An Agreement With Hemcon Medical Technologies

11.7.4 Cardinal Health Acquires VIASYS Healthcare

11.7.5 Cardinal Health Sells Its Pharmaceutical Technologies And Services Segment To The Blackstone Group

11.7.6 Platinum Equity Completes Acquisition Of Healthcare Marketing Services Unit From Cardinal Health

11.7.7 Cardinal Health Enters Into Distribution Agreement With Fisher & Paykel

11.7.8 Cardinal Health And Surgicount Enter Into Co-Marketing Agreement

11.7.9 Cardinal Health Acquires Care Fusion

11.7.10 Cardinal Health Acquires Medmined

11.7.11 Cardinal Health Acquires PET Radiopharmaceutical Production Facilities From Regional Nuclear Pharmaceuticals

11.7.12 Cardinal Health Acquires Wholesale Distribution Businesses From F. Dohmen

11.7.13 Cardinal Health Acquires Denver Biomedical

11.7.14 Cardinal Health Signs An Agreement With Eisai

11.7.15 Cardinal Health Enters Into A Distribution Agreement With Eli Lilly

11.7.16 Cardinal Health Enters Into An Agreement With Monogen

11.7.17 Cardinal Health Acquires ALARIS Medical Systems

11.7.18 Microtek Medical Acquires Certain Businesses Of International Medical And Affiliates From Cardinal

11.7.19 Bespak Enters Into A Co-Marketing Agreement With Cardinal Health

11.7.20 Platinum Equity To Acquire Healthcare Marketing Services Unit Of Cardinal Health

11.7.21 Cardinal Health To Acquire Enturia

11.8 Recent Developments

11.8.1 Apr 01, 2008: Cardiac Science signs letter of intent with Misys Healthcare Systems to connect with their EMR systems

11.8.2 Mar 18, 2008: Cardinal Appoints New Chief Compliance Officer

11.8.3 Mar 13, 2008: Cardinal Names President To Its Pharmaceutical Segment

11.8.4 Feb 20, 2008: Cardiac Science Corporation Schedules Fourth Quarter Earnings Release and Announces Conference Call

11.8.5 Sep 24, 2007: Cardinal Names CEO As Chairman

11.8.6 Aug 08, 2007: Cardinal Health Elects New Director To The Board

11.8.7 Aug 08, 2007: Cardinal Health Declares Quarterly Dividend

11.8.8 Aug 08, 2007: Cardinal Health Announces Share Repurchase Program

11.8.9 May 02, 2007: Cardinal Health Elects New Director

11.8.10 May 02, 2007: Cardinal Health Increases Quarterly Dividend

11.8.11 Jan 31, 2007: Cardinal Health Declares Quarterly Dividend

11.8.12 Jan 31, 2007: Cardinal Health Announces Share Repurchase

11.8.13 Nov 10, 2006: Cardinal Health Names New CEO For Healthcare Supply Chain Services

11.8.14 Nov 08, 2006: Cardinal Health Declares Quarterly Dividend

11.8.15 Nov 08, 2006: Cardinal Health Names New Director

11.8.16 Aug 03, 2006: Cardinal Health Announces Share Repurchase Program

11.8.17 Aug 02, 2006: Cardinal Health Declares Quarterly Dividend

11.8.18 Jul 17, 2006: Cardinal Health Signs Agreement With Premier

11.8.19 Jun 12, 2006: Cardinal Health Announces Fiscal 2007 Outlook

11.8.20 May 10, 2006: Cardinal Health Raises Quarterly Dividend By 50%

11.8.21 Apr 17, 2006: Cardinal Health President and COO Leaves

11.8.22 Apr 17, 2006: Cardinal Health Appoints New President, CEO and Director

12 Covidien Ltd./Tyco Healthcare Company Profile

12.1 Company Overview

12.2 Business Overview

12.2.1 Imaging Solutions

12.2.2 Medical Devices

12.2.3 Medical Supplies

12.2.4 Pharmaceutical Products

12.2.5 Retail Products

12.2.6 Products

12.2.7 History

12.3 Value Chain Analysis

12.3.1 Manufacturing

12.3.2 Product Development

12.3.3 Sales and Marketing

12.4 SWOT Analysis

12.4.1 Covidien Ltd./Tyco Healthcare Strengths

12.4.2 Covidien Ltd./Tyco Healthcare Weaknesses

12.4.3 Covidien Ltd./Tyco Healthcare Opportunities

12.4.4 Covidien Ltd./Tyco Healthcare Threats

12.5 Financial and Operational Review

12.5.1 Financial Statements

12.5.2 Financial Ratios

12.6 Locations And Subsidiaries

12.7 Financial Deals Landscape

12.7.1 Covidien Signs An Agreement With Allergan

12.7.2 Covidien Acquires Scandius Biomedical

12.7.3 Covidien International Finance Completes Private Placement Of $2,750 Million

12.7.4 Covidien And BioSynthema Enter Into Licensing Agreement

12.7.5 Integra LifeSciences Acquires Assets Of Radionics Division From Covidien

12.7.6 Covidien To Sell European Incontinence Business

12.7.7 Covidien To Acquire Tissue Science Laboratories

12.8 Recent Developments

12.8.1 Mar 28, 2008: Covidien Spends $760,000 Lobbying Federal Government In 2007

12.8.2 Mar 18, 2008: Covidien Declares Quarterly Dividend

12.8.3 Feb 21, 2008: Covidien Gests Favorable Decision In Patent Litigation Case

12.8.4 Feb 07, 2008: Covidien Declares Q1 Fiscal 2008 Results

12.8.5 Jan 15, 2008: Covidien Declares Quarterly Dividend

12.8.6 Jan 10, 2008: Covidien To Declare Q1 Fiscal 2008 Results

12.8.7 Dec 06, 2007: Covidien Reports Q4 Fiscal 2007 Results

12.8.8 Oct 04, 2007: Covidien And NewSouth Innovations Collaborate To Develop Novel Imaging Agent

12.8.9 Sep 28, 2007: Covidien Declares Quarterly Dividend

12.8.10 Aug 09, 2007: Covidien Declares Q3 Fiscal 2007 Results

12.9 Covidien Ltd./Tyco Healthcare Pipeline Products

12.9.1 PleuraSeal Lung Sealant System

12.9.2 Sandman Intro CPAP Device

13 Sunrise Medical Company Profile

13.1 Company Overview

13.2 Business Overview

13.2.1 Products

13.2.2 History

13.3 Locations And Subsidiaries

14 Smiths Medical Company Profile

14.1 Company Overview

14.2 Business Overview

14.2.1 Products

14.2.2 History

14.2.3 Manufacturing

14.2.4 Product Development

Regulatory Approvals

14.2.5 Sales and Marketing

14.3 SWOT Analysis

14.3.1 Smiths Medical Strengths

14.3.2 Smiths Medical Weaknesses

14.3.3 Smiths Medical Opportunities

14.3.4 Smiths Medical Threats

1.5 Locations And Subsidiaries

1.6 Financial Deals Landscape

1.6.1 Smiths Medical Signs An Agreement With Inditherm

1.6.2 Smiths Medical And PHASEIN Enter Into Distribution Agreement

1.6.3 Smiths Medical Acquires DHD Healthcare

1.7 Recent Developments

1.7.1 Mar 25, 2008: Smiths Wins Agreements With MedAssets

1.7.2 Sep 26, 2007: Smiths Reports Fiscal 2007 Results

1.7.3 Sep 26, 2007: Smiths Gets New Contracts

1.7.4 Sep 21, 2007: Smiths Appoints New Vice President

1.7.5 May 09, 2007: Smiths Launch Its New Branding In China

1.7.6 Jan 19, 2006: Smiths Appoints New Managing Director

1.8 Smiths Medical Pipeline Products

1.8.1 Suction Above the Cuff ET tube (SACETT)

15 Regulation System

15.1 Medical Equipment Approval Process

15.1.1 Pre-market Approval Process

15.1.2 Intended use and Indications for use

15.1.3 Predicate Device

15.1.4 Safe and Effective

15.1.5 Other Category Devices

15.1.6 Post-Market Approval Process

15.1.7 Compliance and Enforcement

15.1.8 Registration Fee

15.1.9 Approval Time

16 Pricing and Reimbursement

16.1 Government Policies

16.2 Private Insurance

16.3 Diagnosis Related Groups (DRG)

17 Distribution Structure

17.1 Distribution Structure

18 APPENDIX

18.1 Global Markets Direct Research Methodology

18.2 Coverage

18.3 Secondary Research

18.4 Primary Research

18.5 Models

18.6 Forecasts

18.7 Expert Panels

18.8 Currency Conversion

18.9 Contact Us

18.10 Disclaimer

1.1 List of Tables

Table 1: United States Healthcare Expenditure, 2003-2010

Table 2: United States Healthcare Expenditure by Age (per person), 2000-2003

Table 3: United States Healthcare Expenditure by Sex (per person), 2000-2003

Table 4: United States Healthcare Expenditure by Race (per person), 2000-2003

Table 5: United States Personal Healthcare Expenditure by Type, 2000-2004

Table 6: United States Personal Healthcare Expenditure by Source, 2000-2004

Table 7: Total Number of Doctors in the United States, 2003-2010

Table 8: Number of Doctors by Specialty in the United States, 2003-2010

Table 9: Doctors by Region (Number per 10,000 Civilian Population), 2002-2004

Table 10: Doctors by Region (Number per 10,000 Civilian Population), 2002-2004 (Cont.)

Table 11: Total Hospitals in the United States, 2000-2004

Table 12: Community Hospitals by Number of Beds in the United States, 2000-2004

Table 13: Number of Hospital Beds in the United States, 2000-2004

Table 14: Number of Hospital Beds by Range in the United States, 2000-2004

Table 15: Anesthesia and Respiratory Devices, United States, Overall Revenues ($ mn), 2000-2012

Table 16: Anesthesia and Respiratory Devices, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 17: Anesthesia and Respiratory Devices, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 18: Anesthesia and Respiratory Devices, United States, Category Revenues ($ mn), 2000-2012

Table 19: Anesthesia and Respiratory Devices, United States, Category Revenues ($ mn), Historic, 2000-2007

Table 20: Anesthesia and Respiratory Devices, United States, Category Revenues ($ mn), Forecast, 2007-2012

Table 21: Anesthesia and Respiratory Devices, United States, Category Volume (Units), 2000-2012

Table 22: Anesthesia and Respiratory Devices, United States, Category Volume (Units), Historic, 2000-2007

Table 23: Anesthesia and Respiratory Devices, United States, Category Volume (Units), Forecast, 2007-2012

Table 24: Anesthesia and Respiratory Devices in United States, Company Share by Revenue ($ mn), 2005-2006

Table 25: Respiratory Devices, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 26: Respiratory Devices, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 27: Respiratory Devices, United States, Revenue by Segment ($ mn), Historic, 2000-2007

Table 28: Respiratory Devices, United States, Revenue by Segment ($ mn), Forecast, 2007-2012

Table 29: Inhalers, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 30: Inhalers, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 31: Inhalers, United States, Overall Revenues by Sub Segment ($ mn), Forecast, 2000-2007

Table 32: Inhalers, United States, Overall Revenues by Sub Segment ($ mn), Forecast, 2007-2012

Table 33: Metered Dose Inhalers, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 34: Metered Dose Inhalers, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 35: Dry Powder Inhalers, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 36: Dry Powder Inhalers, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 37: Continuous Positive Airway Pressure Devices, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 38: Continuous Positive Airway Pressure Devices, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 39: Nebulizers, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 40: Nebulizers, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 41: Ventilators, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 42: Ventilators, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 43: Humidifiers, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 44: Humidifiers, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 45: Oxygen Concentrator, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 46: Oxygen Concentrator, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 47: Resuscitators, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 48: Resuscitators, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 49: Respiratory Devices, United States, Overall Volume (Units), Historic, 2000-2007

Table 50: Respiratory Devices, United States, Overall Volume (Units), Forecast, 2007-2012

Table 51: Inhalers, United States, Overall Volume (Units), Historic, 2000-2007

Table 52: Inhalers, United States, Overall Volume (Units), Forecast, 2007-2012

Table 53: Inhalers by Sub Segment

Table 54: Inhalers by Sub Segment

Table 55: Metered Dose Inhalers, United States, Overall Volume (Units), Historic, 2000-2007

Table 56: Metered Dose Inhalers, United States, Overall Volume (Units), Forecast, 2007-2012

Table 57: Dry Powder Inhalers, United States, Overall Volume (Units), Historic, 2000-2007

Table 58: Dry Powder Inhalers, United States, Overall Volume (Units), Forecast, 2007-2012

Table 59: Nebulizers, United States, Overall Volume (Units), Historic, 2000-2007

Table 60: Nebulizers, United States, Overall Volume (Units), Forecast, 2007-2012

Table 61: Humidifiers, United States, Overall Volume (Units), Historic, 2000-2007

Table 62: Humidifiers, United States, Overall Volume (Units), Forecast, 2007-2012

Table 63: Ventilators, United States, Overall Volume (Units), Historic, 2000-2007

Table 64: Ventilators, United States, Overall Volume (Units), Forecast, 2007-2012

Table 65: Resuscitators, United States, Overall Volume (Units), Historic, 2000-2007

Table 66: Resuscitators, United States, Overall Volume (Units), Forecast, 2007-2012

Table 67: Continuous Positive Airway Pressure Devices, United States, Overall Volume (Units), Historic, 2000-2007

Table 68: Continuous Positive Airway Pressure Devices, United States, Overall Volume (Units), Forecast, 2007-2012

Table 69: Oxygen Concentrator, United States, Overall Volume (Units), Historic, 2000-2007

Table 70: Oxygen Concentrator, United States, Overall Volume (Units), Forecast, 2007-2012

Table 71: Continuous Positive Airway Pressure Devices, United States, Average Price ($), Historic, 2000-2007

Table 72: Continuous Positive Airway Pressure Devices, United States, Average Price ($), Forecast, 2007-2012

Table 73: Metered Dose Inhalers, United States, Average Price ($), Historic, 2000-2007

Table 74: Metered Dose Inhalers, United States, Average Price ($), Forecast, 2007-2012

Table 75: Dry Powder Inhalers, United States, Average Price ($), Historic, 2000-2007

Table 76: Dry Powder Inhalers, United States, Average Price ($), Forecast, 2007-2012

Table 77: Resuscitators, United States, Average Price ($), Historic, 2000-2007

Table 78: Resuscitators, United States, Average Price ($), Forecast, 2007-2012

Table 79: Ventilators, United States, Average Price ($), Historic, 2000-2007

Table 80: Ventilators, United States, Average Price ($), Forecast, 2007-2012

Table 81: Humidifiers, United States, Average Price ($), Historic, 2000-2007

Table 82: Humidifiers, United States, Average Price ($), Forecast, 2007-2012

Table 83: Nebulizers, United States, Average Price ($), Historic, 2000-2007

Table 84: Nebulizers, United States, Average Price ($), Forecast, 2007-2012

Table 85: Oxygen Concentrator, United States, Average Price ($), Historic, 2000-2007

Table 86: Oxygen Concentrator, United States, Average Price ($), Forecast, 2007-2012

Table 87: Respiratory Devices, United States, Distribution Share by Revenue ($ mn), 2005-2006

Table 88: Respiratory Devices, United States, Company Share by Revenue ($ mn), 2005-2006

Table 89: Respiratory Measurement Devices, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 90: Respiratory Measurement Devices, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 91: Respiratory Measurement Devices, United States, Revenue by Segment ($ mn), Historic, 2000-2007

Table 92: Respiratory Measurement Devices, United States, Revenue by Segment ($ mn), Forecast, 2007-2012

Table 93: Pulse Oximetry Sensors, United States, Overall Revenues ($ mn), Historic, 2000-2007

Table 94: Pulse Oximetry Sensors, United States, Overall Revenues ($ mn), Forecast, 2007-2012

Table 95: Capnographs, United States, Overall Revenues ($ mn), Historic, 2000-2007

Abstract

• The report provides anesthesia & respiratory devices market information broken down into detailed categories and segments in United States.
• Total revenues, products sold, end users, and average pricing.
• Market shares of all the key competitors.
• Key pipeline products that are set to shape the market, broken down by sector.
• Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
• Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
• Key mergers and acquisitions, partnerships, private equity investments and IPOs.
• Customer, hospitals and physicians data.

• Gain a strong understanding of the industry at a global level, with break downs for the country
• Evaluate and compare the attractiveness of the market in the country.
• Identify growth segments and opportunities in each industry sector within the country.
• Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
• Analyze the competitiveness of the market in the country and identify hotspots.
• Develop strategies based on the latest product, brand, expansion and research and development news in the country.
• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
• Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 300,000 market research reports, company profiles and country profiles from over 700 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.